ArticleCommunications biology2026
DTX1-mediated degradation of TUBB3 in Kupffer cells mitigates hepatocellular carcinoma progression by regulating M1/M2 polarization.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A high infiltration of tumor-associated macrophages (TAMs) in hepatocellular carcinoma (HCC) is associated with a negative prognosis for patients. Kupffer cells (KCs) constitute a stationary tissue-resident macrophage subset of the liver, playing a pivotal role in maintaining homeostasis. The increased expression of tubulin beta-3 chain (TUBB3) is associated with the aggressiveness of various epithelial tumors. In this study, we investigate the role of TUBB3 in TAM of HCC and explore the mechanisms. TUBB3 is significantly augmented in HCC tissues, and the knockdown of TUBB3 in Kupffer cells (KCs) inhibits M2 polarization of TAM and hinders the HCC progression. In addition, TUBB3 knockdown enhances the efficacy of PD-1 immunotherapy in vivo. TUBB3 inhibits phosphatase and tensin homolog (PTEN)-induced serine-threonine protein kinase (AKT) phosphorylation, and activation of the AKT signaling reverses the inhibition of TAM-M2 polarization by knockdown of TUBB3 and promotes the malignant behavior of HCC cells. Deltex1 (DTX1) promotes TUBB3 ubiquitination, inducing the degradation of TUBB3. DTX1 overexpression suppresses the M2 polarization of TAM, which is overturned by TUBB3 overexpression. These findings provide the first evidence indicating that DTX1 mediates the ubiquitination of TUBB3 in KCs to block the AKT signaling and the M2 polarization of TAM in HCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.